Evidence map›Paper›PMID 26656119›Full record

ArticleClinical and vaccine immunology : CVI2016

Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort.

Arlene E Dent, Indu Malhotra, Xuelie Wang, Denise Babineau, Kee Thai Yeo, Timothy Anderson, Rhonda J Kimmel, Evelina Angov, David E Lanar, David Narum and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Dynamics of IgG antibody response againstFrontiers in immunology · 2023
    Article
  6. Article
  7. Article
  8. Microscopic and submicroscopic infection byFrontiers in cellular and infection microbiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Arlene E DentCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA arlene.dent@case.edu.
Indu MalhotraCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Xuelie WangDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA.
Denise BabineauDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA.
Kee Thai YeoDepartment of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Timothy AndersonSchool of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Rhonda J KimmelCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Evelina AngovMalaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
David E LanarMalaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
David NarumLaboratory of Malaria Immunology and Vaccinology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Sheetij DuttaMalaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Jack RichardsBurnet Institute, Melbourne, Australia.
James G BeesonBurnet Institute, Melbourne, Australia Department of Microbiology, Monash University, Melbourne, Australia.
Brendan S CrabbBurnet Institute, Melbourne, Australia.
Alan F CowmanWalter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Toshihiro HoriiDepartment of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Eric MuchiriDivision of Vector Borne and Neglected Tropical Diseases, Ministry of Public Health and Sanitation, Nairobi, Kenya.
Peter L MungaiCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA Division of Vector Borne and Neglected Tropical Diseases, Ministry of Public Health and Sanitation, Nairobi, Kenya.
Christopher L KingCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
James W KazuraCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Case Western Reserve University · USBurnet Institute · AUWalter Reed Army Institute of Research · USCenter for Global Health · USMinistry of Health · KERainbow Babies & Children's Hospital · USNational Institutes of Health · USOsaka University · JPWalter and Eliza Hall Institute of Medical Research · AU

Funding

Fetal Immunity to Falciparum MalariaR01AI064687 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KING, CHRISTOPHER L · 2005 to 2015
$3.7M
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in KenR01AI095192 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2011 to 2015
$3.2M
B cell immunity in HIV exposed uninfected infants in KenyaR01AI098511 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI DENT, ARLENE · 2012 to 2015
$2.5M
NIAID NIH HHS R01 AI064687NIAID NIH HHS R01 AI095192NIAID NIH HHS R01 AI098511
6 · The paper itself

Abstract

IgG antibodies to Plasmodium falciparum are transferred from the maternal to fetal circulation during pregnancy, wane after birth, and are subsequently acquired in response to natural infection. We examined the dynamics of malaria antibody responses of 84 Kenyan infants from birth to 36 months of age by (i) serology, (ii) variant surface antigen (VSA) assay, (iii) growth inhibitory activity (GIA), and (iv) invasion inhibition assays (IIA) specific for merozoite surface protein 1 (MSP1) and sialic acid-dependent invasion pathway. Maternal antibodies in each of these four categories were detected in cord blood and decreased to their lowest level by approximately 6 months of age. Serologic antibodies to 3 preerythrocytic and 10 blood-stage antigens subsequently increased, reaching peak prevalence by 36 months. In contrast, antibodies measured by VSA, GIA, and IIA remained low even up to 36 months. Infants sensitized to P. falciparum in utero, defined by cord blood lymphocyte recall responses to malaria antigens, acquired antimalarial antibodies at the same rate as those who were not sensitized in utero, indicating that fetal exposure to malaria antigens did not affect subsequent infant antimalarial responses. Infants with detectable serologic antibodies at 12 months of age had an increased risk of P. falciparum infection during the subsequent 24 months. We conclude that serologic measures of antimalarial antibodies in children 36 months of age or younger represent biomarkers of malaria exposure rather than protection and that functional antibodies develop after 36 months of age in this population.

Indexed as

Age FactorsAntibodies, ProtozoanAntigens, ProtozoanBiomarkersChild, PreschoolFemaleFetal BloodHumansImmunity, Maternally-AcquiredImmunoglobulin GImmunoglobulin MInfantInfant, NewbornKenyaMalaria, FalciparumMaleAntibodies, ProtozoanAntigens, ProtozoanBiomarkersImmunoglobulin GImmunoglobulin MMerozoite Surface Protein 1Protozoan Proteins

Identifiers

PMID26656119
PMCPMC4744923
OpenAlexW2256050882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.